Peter Pitts's profile photo

Peter Pitts

Featured in: Favicon nature.com Favicon wsj.com Favicon cnbc.com Favicon latimes.com Favicon nydailynews.com Favicon nypost.com Favicon newsweek.com Favicon yahoo.com Favicon ibtimes.com Favicon springer.com

Articles

  • 2 months ago | medcitynews.com | Peter Pitts |Stephanie Baum

    In 2017, President Trump declared the opioid epidemic – which then was taking the lives of over 100 people each day – to be the “worst drug crisis in American history”. As he returns to office and the next presidential administration takes form, folks are debating which issues should be prioritized over the coming term. It is critical they remember the addiction crisis our country still faces now in 2025 in their plans.

  • Oct 17, 2024 | statnews.com | Peter Pitts

    Andrew Harnik/AP By Peter J.

  • Oct 10, 2024 | americanmind.org | Robert Goldberg |Peter Pitts

    Price controls will never be able to effectively control cost.

  • Oct 10, 2024 | americanmind.org | Robert Goldberg |Peter Pitts

    Blood cancer is one of the disease’s most treatable forms. Thanks to decades of research, it’s become easy to eradicate through treatments like chemotherapy, radiation, and even techniques that use the body’s immune system to attack cancer cells. It’s an optimistic outlook for the more than that suffer from the disease. Yet one might be surprised to hear that drug companies are abandoning these treatments en masse.

  • Sep 19, 2024 | washingtontimes.com | Peter Pitts

    OPINION: Compounding pharmacies that offer their own homebrew GLP-1 drugs are the new designer smoke shops: Illegal, unsafe, and popping up on every street corner in upper-income zip codes. What? Your doctor won’t prescribe you Ozempic, Zepbound, Wegovy, or Mounjaro for off-label weight loss? No problem. If you’re willing to pay cash, there are plenty of compounding pharmacies ready to give you what you want. And plenty of websites too.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →